Erratum to Role of intestinal microbiota in the generation of polyphenol derived phenolic acid mediated attenuation of Alzheimer's disease β-amyloid oligomerization[Mol. Nutr. Food. Res. 59, (2015), 1025-1040, DOI: 10.1002/mnfr.201400544];Role of intestinal microbiota in the generation of polyphenol-derived phenolic acid mediated attenuation of Alzheimer's disease β-amyloid oligomerization

Molecular Nutrition and Food Research

Volumn 59, Issue 6, 2015, Pages 1025-1040

  Wang, Dongjie ^a   Ho, Lap ^b   Faith, Jeremiah ^b   Ono, Kenjiro ^c   Janle, Elsa M ^d   Lachcik, Pamela J ^d   Cooper, Bruce R ^e   Jannasch, Amber H ^e   D'Arcy, Bruce R ^a   Williams, Barbara A ^a   Ferruzzi, Mario G ^d,e   Levine, Samara ^b   Zhao, Wei ^b   Dubner, Lauren ^b   Pasinetti, Giulio M ^b,f  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^d PURDUE UNIVERSITY   (United States)

^e PURDUE UNIVERSITY   (United States)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Bioavailability; Grape seed polyphenol extract; Phenolic metabolites; Proanthocyanidins; Amyloid

Indexed keywords

RATTUS; VITACEAE;

3-HYDROXYBENZOIC ACID; 3-HYDROXYPHENYLPROPIONIC ACID; AMYLOID BETA PROTEIN; AMYLOID BETA-PROTEIN (1-42); ANTHOCYANIN; GRAPE SEED EXTRACT; HYDROXYBENZOIC ACID DERIVATIVE; PEPTIDE FRAGMENT; PHENOL DERIVATIVE; PHENOLIC ACID; POLYPHENOL; PROPIONIC ACID DERIVATIVE;

ALZHEIMER DISEASE; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOAVAILABILITY; BLOOD; BRAIN; DRUG EFFECTS; FERMENTATION; INTESTINE; INTESTINE FLORA; MALE; METABOLISM; MICROBIOLOGY; RAT; SPRAGUE DAWLEY RAT;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; ANTHOCYANINS; BIOLOGICAL AVAILABILITY; BRAIN; FERMENTATION; GASTROINTESTINAL MICROBIOME; GRAPE SEED EXTRACT; HYDROXYBENZOATES; INTESTINES; MALE; PEPTIDE FRAGMENTS; PHENOLS; POLYPHENOLS; PROPIONATES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84930179301     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201570114     Document Type: Erratum

References (76)

1. Wang, J., Ho, L., Zhao, W., Ono, K. et al., Grape-derived polyphenolics prevent Abeta oligomerization and attenuate cognitive deterioration in a mouse model of Alzheimer's disease. J. Neurosci. 2008, 28, 6388-6392.
2. Santa-Maria, I., az-Ruiz, C., Ksiezak-Reding, H., Chen, A. et al., GSPE interferes with tau aggregation in vivo: implication for treating tauopathy. Neurobiol. Aging 2012, 33, 2072-2081.
3. Wang, J., Santa-Maria, I., Ho, L., Ksiezak-Reding, H. et al., Grape derived polyphenols attenuate tau neuropathology in a mouse model of Alzheimer's disease. J. Alzheimers Dis. 2010, 22, 653-661.
4. Sivaprakasapillai, B., Edirisinghe, I., Randolph, J., Steinberg, F. et al., Effect of grape seed extract on blood pressure in subjects with the metabolic syndrome. Metabolism 2009, 58, 1743-1746.
5. Ward, N. C., Hodgson, J. M., Croft, K. D., Burke, V. et al., The combination of vitamin C and grape-seed polyphenols increases blood pressure: a randomized, double-blind, placebo-controlled trial. J. Hypertens. 2005, 23, 427-434.
6. Ras, R. T., Zock, P. L., Zebregs, Y. E., Johnston, N. R. et al., Effect of polyphenol-rich grape seed extract on ambulatory blood pressure in subjects with pre- and stage I hypertension. Br. J Nutr. 2013, 110, 2234-2241.
7. Dinicola, S., Cucina, A., Pasqualato, A., Proietti, S. et al., Apoptosis-inducing factor and caspase-dependent apoptotic pathways triggered by different grape seed extracts on human colon cancer cell line Caco-2. Br. J. Nutr. 2010, 104, 824-832.
8. Singletary, K. W., Meline, B., Effect of grape seed proanthocyanidins on colon aberrant crypts and breast tumors in a rat dual-organ tumor model. Nutr. Cancer 2001, 39, 252-258.
9. Agarwal, C., Sharma, Y., Zhao, J., Agarwal, R., A polyphenolic fraction from grape seeds causes irreversible growth inhibition of breast carcinoma MDA-MB468 cells by inhibiting mitogen-activated protein kinases activation and inducing G1 arrest and differentiation. Clin. Cancer Res. 2000, 6, 2921-2930.
10. Kim, H., Hall, P., Smith, M., Kirk, M. et al., Chemoprevention by grape seed extract and genistein in carcinogen-induced mammary cancer in rats is diet dependent. J. Nutr. 2004, 134, 3445S-3452S.
11. Manach, C., Scalbert, A., Morand, C., Remesy, C. et al., Polyphenols: food sources and bioavailability. Am. J. Clin. Nutr. 2004, 79, 727-747.
12. Sano, A., Yamakoshi, J., Tokutake, S., Tobe, K. et al., Procyanidin B1 is detected in human serum after intake of proanthocyanidin-rich grape seed extract. Biosci. Biotechnol. Biochem. 2003, 67, 1140-1143.
13. Wang, J., Ferruzzi, M. G., Ho, L., Blount, J. et al., Brain-targeted proanthocyanidin metabolites for Alzheimer's disease treatment. J. Neurosci. 2012, 32, 5144-5150.
14. Ho, L., Pasinetti, G. M., Polyphenolic compounds for treating neurodegenerative disorders involving protein misfolding. Expert. Rev. Proteomics 2010, 7, 579-589.
15. Du, Y., Lou, H., Catechin and proanthocyanidin B4 from grape seeds prevent doxorubicin-induced toxicity in cardiomyocytes. Eur. J. Pharmacol. 2008, 591, 96-101.
16. Leifert, W. R., Abeywardena, M. Y., Cardioprotective actions of grape polyphenols. Nutr. Res. 2008, 28, 729-737.
17. Sato, M., Bagchi, D., Tosaki, A., Das, D. K., Grape seed proanthocyanidin reduces cardiomyocyte apoptosis by inhibiting ischemia/reperfusion-induced activation of JNK-1 and C-JUN. Free Radic. Biol. Med. 2001, 31, 729-737.
18. Ferruzzi, M. G., Lobo, J. K., Janle, E. M., Cooper, B. et al., Bioavailability of gallic acid and catechins from grape seed polyphenol extract is improved by repeated dosing in rats: implications for treatment in Alzheimer's disease. J. Alzheimers. Dis. 2009, 18, 113-124.
19. Nakamura, Y., Tonogai, Y., Metabolism of grape seed polyphenol in the rat. J. Agric. Food Chem. 2003, 51, 7215-7225.
20. Tsang, C., Auger, C., Mullen, W., Bornet, A. et al., The absorption, metabolism and excretion of flavan-3-ols and procyanidins following the ingestion of a grape seed extract by rats. Br. J. Nutr. 2005, 94, 170-181.
21. Aura, A. M., O'Leary, K. A., Williamson, G., Ojala, M. et al., Quercetin derivatives are deconjugated and converted to hydroxyphenylacetic acids but not methylated by human fecal flora in vitro. J. Agric. Food Chem. 2002, 50, 1725-1730.
22. Cueva, C., Sanchez-Patan, F., Monagas, M., Walton, G. E. et al., In vitro fermentation of grape seed flavan-3-ol fractions by human faecal microbiota: changes in microbial groups and phenolic metabolites. FEMS Microbiol. Ecol. 2013, 83, 792-805.
23. Gonthier, M. P., Donovan, J. L., Texier, O., Felgines, C. et al., Metabolism of dietary procyanidins in rats. Free Radic. Biol. Med. 2003, 35, 837-844.
24. Wang, L. Q., Meselhy, M. R., Li, Y., Nakamura, N. et al., The heterocyclic ring fission and dehydroxylation of catechins and related compounds by Eubacterium sp. strain SDG-2, a human intestinal bacterium. Chem. Pharm. Bull. 2001, 49, 1640-1643.
25. Unno, T., Tamemoto, K., Yayabe, F., Kakuda, T., Urinary excretion of 5-(3′, 4′-dihydroxyphenyl)-gamma-valerolactone, a ring-fission metabolite of (-)-epicatechin, in rats and its in vitro antioxidant activity. J. Agric. Food Chem. 2003, 51, 6893-6898.
26. Hasslauer, I., Oehme, A., Locher, S., Valotis, A. et al., Flavan-3-ol C-glycosides-preparation and model experiments mimicking their human intestinal transit. Mol. Nutr. Food Res. 2010, 54, 1546-1555.
27. Keppler, K., Humpf, H. U., Metabolism of anthocyanins and their phenolic degradation products by the intestinal microflora. Bioorg. Med. Chem. 2005, 13, 5195-5205.
28. Gonthier, M. P., Verny, M. A., Besson, C., Remesy, C. et al., Chlorogenic acid bioavailability largely depends on its metabolism by the gut microflora in rats. J. Nutr. 2003, 133, 1853-1859.
29. Olthof, M. R., Hollman, P. C., Buijsman, M. N., vanAmelsvoort, J. M. et al., Chlorogenic acid, quercetin-3-rutinoside and black tea phenols are extensively metabolized in humans. J. Nutr. 2003, 133, 1806-1814.
30. Rechner, A. R., Smith, M. A., Kuhnle, G., Gibson, G. R. et al., Colonic metabolism of dietary polyphenols: influence of structure on microbial fermentation products. Free Radic. Biol. Med. 2004, 36, 212-225.
31. Deprez, S., Brezillon, C., Rabot, S., Philippe, C. et al., Polymeric proanthocyanidins are catabolized by human colonic microflora into low-molecular-weight phenolic acids. J. Nutr. 2000, 130, 2733-2738.
32. Wang, D., Williams, B. A., Ferruzzi, M. G., D'Arcy, B. R., Different concentrations of grape seed extract affect in vitro starch fermentation by porcine small and large intestinal inocula. J. Sci. Food Agric. 2013, 93, 276-283.
33. Gonthier, M. P., Cheynier, V., Donovan, J. L., Manach, C. et al., Microbial aromatic acid metabolites formed in the gut account for a major fraction of the polyphenols excreted in urine of rats fed red wine polyphenols. J. Nutr. 2003, 133, 461-467.
34. Prior, R. L., Rogers, T. R., Khanal, R. C., Wilkes, S. E. et al., Urinary excretion of phenolic acids in rats fed cranberry. J. Agric. Food Chem. 2010, 58, 3940-3949.
35. Ward, N. C., Croft, K. D., Puddey, I. B., Hodgson, J. M., Supplementation with grape seed polyphenols results in increased urinary excretion of 3-hydroxyphenylpropionic acid, an important metabolite of proanthocyanidins in humans. J. Agric. Food Chem. 2004, 52, 5545-5549.
36. Baba, S., Osakabe, N., Natsume, M., Muto, Y. et al., Absorption and urinary excretion of (-)-epicatechin after administration of different levels of cocoa powder or (-)-epicatechin in rats. J. Agric. Food Chem. 2001, 49(12), 6050-6056.
37. Prasain, J. K., Peng, N., Dai, Y., Moore, R. et al., Liquid chromatography tandem mass spectrometry identification of proanthocyanidins in rat plasma after oral administration of grape seed extract. Phytomedicine 2009, 16, 233-243.
38. Lotito, S. B., Frei, B., Consumption of flavonoid-rich foods and increased plasma antioxidant capacity in humans: cause, consequence, or epiphenomenon? Free Radic. Biol. Med. 2006, 41, 1727-1746.
39. Calani, L., Dall'Asta, M., Derlindati, E., Scazzina, F. et al., Colonic metabolism of polyphenols from coffee, green tea, and hazelnut skins. J. Clin. Gastroenterol. 2012, 46, S95-S99.
40. Monagas, M., Urpi-Sarda, M., Sanchez-Patan, F., Llorach, R. et al., Insights into the metabolism and microbial biotransformation of dietary flavan-3-ols and the bioactivity of their metabolites. Food Funct. 2010, 1, 233-253.
41. Aura, A.-M., Mattila, I., Seppänen-Laakso, T., Miettinen, J. et al., Microbial metabolism of catechin stereoisomers by human faecal microbiota: comparison of targeted analysis and a non-targeted metabolomics method. Phytochem. Lett. 2008, 1, 18-22.
42. Monagas, M., Urpi-Sarda, M., Sanchez-Patan, F., Llorach, R. et al., Insights into the metabolism and microbial biotransformation of dietary flavan-3-ols and the bioactivity of their metabolites. Food Funct. 2010, 1, 233-253.
43. Rechner, A. R., Spencer, J. P., Kuhnle, G., Hahn, U. et al., Novel biomarkers of the metabolism of caffeic acid derivatives in vivo. Free Radic. Biol. Med. 2001, 30, 1213-1222.
44. Feng, W. Y., Metabolism of green tea catechins: an overview. Curr. Drug Metab. 2006, 7, 755-809.
45. Rechner, A. R., Smith, M. A., Kuhnle, G., Gibson, G. R. et al., Colonic metabolism of dietary polyphenols: influence of structure on microbial fermentation products. Free Radic. Biol. Med. 2004, 36, 212-225.
46. Wu, C., Pittman, H. E., Hager, T., Hager, A. et al., Phenolic acids in black raspberry and in the gastrointestinal tract of pigs following ingestion of black raspberry. Mol. Nutr. Food Res. 2009, 53 (Suppl. 1), S76-S84.
47. Hwang, I. K., Yoo, K. Y., Kim, D. S., Jeong, Y. K. et al., Neuroprotective effects of grape seed extract on neuronal injury by inhibiting DNA damage in the gerbil hippocampus after transient forebrain ischemia. Life Sci. 2004, 75, 1989-2001.
48. Saura-Calixto, F., Perez-Jimenez, J., Tourino, S., Serrano, J. et al., Proanthocyanidin metabolites associated with dietary fibre from in vitro colonic fermentation and proanthocyanidin metabolites in human plasma. Mol. Nutr. Food Res. 2010, 54, 939-946.
49. Walsh, D. M., Lomakin, A., Benedek, G. B., Condron, M. M. et al., Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate. J. Biol. Chem. 1997, 272, 22364-22372.
50. Teplow, D. B., Preparation of amyloid beta-protein for structural and functional studies. Methods Enzymol. 2006, 413, 20-33.
51. Ono, K., Condron, M. M., Ho, L., Wang, J. et al., Effects of grape seed-derived polyphenols on amyloid beta-protein self-assembly and cytotoxicity. J. Biol. Chem. 2008, 283, 32176-32187.
52. Bitan, G., Lomakin, A., Teplow, D. B., Amyloid beta-protein oligomerization: prenucleation interactions revealed by photo-induced cross-linking of unmodified proteins. J. Biol. Chem. 2001, 276, 35176-35184.
53. Appeldoorn, M. M., Vincken, J. P., Aura, A. M., Hollman, P. C. et al., Procyanidin dimers are metabolized by human microbiota with 2-(3, 4-dihydroxyphenyl)acetic acid and 5-(3, 4-dihydroxyphenyl)-gamma-valerolactone as the major metabolites. J. Agric. Food Chem. 2009, 57, 1084-1092.
54. Aura, A. M., Microbial metabolism of dietary phenolic compounds in the colon. Phytochem. Rev. 2008, 7, 407-429.
55. Bitan, G., Kirkitadze, M. D., Lomakin, A., Vollers, S. S. et al., Amyloid beta -protein (Abeta) assembly: Abeta 40 and Abeta 42 oligomerize through distinct pathways. Proc. Natl. Acad. Sci. USA 2003, 100, 330-335.
56. Bitan, G., Fradinger, E. A., Spring, S. M., Teplow, D. B., Neurotoxic protein oligomers-what you see is not always what you get. Amyloid 2005, 12, 88-95.
57. Wang, Y. J., Thomas, P., Zhong, J. H., Bi, F. F. et al., Consumption of grape seed extract prevents amyloid-beta deposition and attenuates inflammation in brain of an Alzheimer's disease mouse. Neurotox. Res. 2009, 15, 3-14.
58. Gao, K., Xu, A., Krul, C., Venema, K. et al., Of the major phenolic acids formed during human microbial fermentation of tea, citrus, and soy flavonoid supplements, only 3, 4-dihydroxyphenylacetic acid has antiproliferative activity. J. Nutr. 2006, 136, 52-57.
59. Serafim, T. L., Carvalho, F. S., Marques, M. P., Calheiros, R. et al., Lipophilic caffeic and ferulic acid derivatives presenting cytotoxicity against human breast cancer cells. Chem. Res. Toxicol. 2011, 24, 763-774.
60. Lin, Y., Yan, Y., Biosynthesis of caffeic acid in Escherichia coli using its endogenous hydroxylase complex. Microb. Cell Fact. 2012, 11, 42-50.
61. Cui, J. D., Qiu, J. Q., Fan, X. W., Jia, S. R. et al., Biotechnological production and applications of microbial phenylalanine ammonia lyase: a recent review. Crit. Rev. Biotechnol. 2014, 34, 258-268.
62. Urpi-Sarda, M., Monagas, M., Khan, N., Llorach, R. et al., Targeted metabolic profiling of phenolics in urine and plasma after regular consumption of cocoa by liquid chromatography-tandem mass spectrometry. J. Chromatogr. A 2009, 1216, 7258-7267.
63. Faria, A., Pestana, D., Teixeira, D., Couraud, P. O. et al., Insights into the putative catechin and epicatechin transport across blood-brain barrier. Food Funct. 2011, 2, 39-44.
64. Clabough, E. B., Huntington's disease: the past, present, and future search for disease modifiers. Yale J. Biol. Med. 2013, 86, 217-233.
65. Duyckaerts, C., Neurodegenerative lesions: seeding and spreading. Rev. Neurol. 2013, 169, 825-833.
66. Dimakopoulos, A. C., Protein aggregation in Alzheimer's disease and other neoropathological disorders. Curr. Alzheimer Res. 2005, 2, 19-28.
67. Scalbert, A., Williamson, G., Dietary intake and bioavailability of polyphenols. J. Nutr. 2000, 130, 2073S-2085S.
68. Kim, B. S., Jeon, Y. S., Chun, J., Current status and future promise of the human microbiome. Pediatr. Gastroenterol. Hepatol. Nutr. 2013, 16, 71-79.
69. Power, S. E., O'Toole, P. W., Stanton, C., Ross, R. P. et al., Intestinal microbiota, diet and health. Br. J Nutr. 2014, 111, 387-402.
70. Basli, A., Soulet, S., Chaher, N., Merillon, J. M. et al., Wine polyphenols: potential agents in neuroprotection. Oxid. Med. Cell. Longev. 2012, 2012, 1-14.
71. Cimini, A., Gentile, R., D'Angelo, B., Benedetti, E. et al., Cocoa powder triggers neuroprotective and preventive effects in a human Alzheimer's disease model by modulating BDNF signaling pathway. J. Cell. Biochem. 2013, 114, 2209-2220.
72. Magrone, T., Marzulli, G., Jirillo, E., Immunopathogenesis of neurodegenerative diseases: current therapeutic models of neuroprotection with special reference to natural products. Curr. Pharm. Des. 2012, 18, 34-42.
73. Smid, S. D., Maag, J. L., Musgrave, I. F., Dietary polyphenol-derived protection against neurotoxic beta-amyloid protein: from molecular to clinical. Food Funct. 2012, 3, 1242-1250.
74. Tavares, L., Figueira, I., McDougall, G. J., Vieira, H. L. et al., Neuroprotective effects of digested polyphenols from wild blackberry species. Eur. J. Nutr. 2013, 52, 225-236.
75. Virmani, A., Pinto, L., Binienda, Z., Ali, S., Food, nutrigenomics, and neurodegeneration-neuroprotection by what you eat! Mol. Neurobiol. 2013, 48, 353-362.
76. Wang, J., Tang, C., Ferruzzi, M. G., Gong, B. et al., Role of standardized grape polyphenol preparation as a novel treatment to improve synaptic plasticity through attenuation of features of metabolic syndrome in a mouse model. Mol. Nutr. Food Res. 2013, 57, 2091-2102.